Algert Global LLC Geron Corp Transaction History
Algert Global LLC
- $4.04 Billion
- Q1 2025
A detailed history of Algert Global LLC transactions in Geron Corp stock. As of the latest transaction made, Algert Global LLC holds 3,260,934 shares of GERN stock, worth $5.09 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
3,260,934
Previous 528,686
516.8%
Holding current value
$5.09 Million
Previous $1.87 Million
176.98%
% of portfolio
0.13%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding GERN
# of Institutions
295Shares Held
496MCall Options Held
799KPut Options Held
463K-
Ra Capital Management, L.P. Boston, MA60.4MShares$94.2 Million1.99% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$72.6 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT38.2MShares$59.6 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.1MShares$53.3 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$42.5 Million11.75% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $589M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...